In line with the hypothesis of a correlation between NOS and AD, a 50% reduction in the activity of sGC has been reported in soluble fractions from the temporal cortex of AD patients [48], while low expression levels of sGC were observed in reactive astrocytes surrounding Aβ plaques [49]. Here, SGCB is linked to Alzheimer disease.